A descriptive study of aripiprazole, brexpiprazole, and cariprazine exposures in children ages 0 to 5 years reported to United States poison centers

References

• Gummin DD, Mowry JB, Beuhler MC, et al. 2020 Annual report of the American association of poison control centers. National Poison Data System (NPDS): 38th Annual Report. Clin Toxicol. 2021;59:1282–1501.
   PubMed Web of Science ®Google Scholar
• Cobaugh DJ, Erdman AR, Booze LL, et al. Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45(8):918–942.
   PubMed Web of Science ®Google Scholar
• Olfson M, Blanco C, Liu S-M, et al. National trends in the Office-Based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry. 2012;69(12):1247–1256.
   PubMed Web of Science ®Google Scholar
• Nevo N, Mehta S, Chan V, et al. Pediatric postmarketing pharmacovigilance and drug utilization review: abilify (aripiprazole) [Internet] United States Food and Drug Administration. Report No.: 4095788. 2017. https://www.fda.gov/media/107289/download
   Google Scholar
• Burghardt LC, Ayers JW, Brownstein JS, et al. Adult prescription drug use and pediatric medication exposures and poisonings. Pediatrics. 2013;132(1):18–27.
   PubMed Web of Science ®Google Scholar
• Stassinos G, Klein-Schwartz W. Comparison of pediatric atypical antipsychotic exposures reported to U.S. poison centers. Clin Toxicol. 2017;55(1):40–45.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Data table of infant weight-for-age charts, ages birth to 36 months [Internet]. Data table infant weight–age charts ages birth 36 Mon. 2001. https://www.cdc.gov/growthcharts/html_charts/wtageinf.htm
   Google Scholar
• Centers for Disease Control and Prevention. Data table of weight-for-age charts ages 2-20 years [internet]. data table weight–age charts ages 2-20 years. 2001. https://www.cdc.gov/growthcharts/html_charts/wtage.htm
   Google Scholar
• Stassinos G, Klein-Schwartz W. Asenapine, iloperidone and lurasidone exposures in young children reported to U.S. poison centers. Clin Toxicol. 2018;56(5):355–359.
   PubMed Web of Science ®Google Scholar
• Schonberger RB, Douglas L, Baum CR. Severe extrapyramidal symptoms in a 3-Year-Old boy after accidental ingestion of the new antipsychotic drug aripiprazole. Pediatrics. 2004;114(6):1743–1743.
   PubMed Web of Science ®Google Scholar
• Davenport JD, McCarthy MW, Buck ML. Excessive somnolence from aripiprazole in a child. Pharmacotherapy. 2004;24(4):522–525.
   PubMed Web of Science ®Google Scholar
• Lofton A, Klein-Schwartz W. Atypical experience: a case series of pediatric aripiprazole exposures. Clin Toxicol (Phila). 2005;43(3):151–153.
   PubMed Web of Science ®Google Scholar
• Seifert S, Schwartz M, Thomas J. Aripiprazole (AbilifyTM) overdose in a child. Clin Toxicol. 2005;43(3):193–195.
   Web of Science ®Google Scholar
• Melhem S, Katz K, Jameson A, et al. Prolonged toxicity in a 2-Year-Old after accidental ingestion of aripiprazole. Pediatr Emerg Care. 2009;25:105–106.
   PubMed Web of Science ®Google Scholar
• Wong S, Goto C, Wax P, et al. Delayed seizures and prolonged toxicity due to pediatric aripiprazole overdose (abstract). Clin Toxicol Phila Pa. 2009;47:727.
   Web of Science ®Google Scholar
• Thabet FI, Sweis RT, Joseph SA. Aripiprazole-Induced seizure in a 3-Year-Old child: a case report and literature review. Clin Neuropharmacol. 2013;36(1):29–30.
   PubMed Web of Science ®Google Scholar
• Kaplan J, Shah P, Faley B, et al. Case reports of aripiprazole causing False-Positive urine amphetamine drug screens in children. Pediatrics. 2015;136(6):e1625–e1628.
   PubMed Web of Science ®Google Scholar
• Anastasiou-Katsiardani A, Tanou K, Korka Z, et al. A case of Drug-Induced encephalopathy in a thirteen—month old toddler as a result of accidental ingestion of aripiprazole: a pediatric case report (abstract). Cogent Med. 2019;6:78–79.
   Google Scholar
• Gupta D, OʼHara C. Aripiprazole toxicity with a biphasic course of somnolence. Pediatr Emerg Care. 2019;35(8):e145–e146.
   PubMed Web of Science ®Google Scholar
• United State Food and Drug Administration. Review and evaluation of clinical data. Aripiprazole. [Internet]. 2003. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/21-436_Abilify_medr_P3.pdf
   Google Scholar
• Rodriguez SA, Moss MJ. Pediatric brexpiprazole toxicity. Clin Toxicol. 2020;58(12):1354–1355.
   PubMed Web of Science ®Google Scholar
• Brandehoff N, Marlin M. Pediatric ingestion of cariprazine causing bimodal CNS depression and thrombocytopenia: a case report. Clin Toxicol. 2017;55(7):715.
   Google Scholar
• Laszlovszky I, Barabássy Á, Németh G. Cariprazine, a Broad-Spectrum antipsychotic for the treatment of schizophrenia: pharmacology, efficacy, and safety. Adv Ther. 2021;38(7):3652–3673.
   PubMed Web of Science ®Google Scholar
• Edinoff AN, Wu NW, Maxey BS, et al. Brexpiprazole for the treatment of schizophrenia and major depressive disorder: a comprehensive review of pharmacological considerations in clinical practice. Psychopharmacol Bull. 2021;51(2):69–95.
   PubMedGoogle Scholar
• Riva MA, Sciascio DG. Aripiprazole: from pharmacological profile to clinical use. Neuropsychiatr Dis Treat. 2015;11:2635–2647.
   PubMed Web of Science ®Google Scholar
• Kinghorn WA, McEvoy JP. Aripiprazole: pharmacology, efficacy, safety and tolerability. Expert Rev Neurother. 2005;5(3):297–307.
   PubMedGoogle Scholar
• Stahl SM. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 1: “goldilocks” actions at dopamine receptors: (brainstorms). J. Clin. Psychiatry. 2001;62(11):841–842.
   PubMed Web of Science ®Google Scholar
• Mailman R, Murthy V. Third generation antipsychotic drugs: partial agonism or receptor functional selectivity? Curr Pharm Des. 2010;16(5):488–501.
   PubMed Web of Science ®Google Scholar
• Fleischhacker WW. Aripiprazole. Expert Opin Pharmacother. 2005;6(12):2091–2101.
   PubMed Web of Science ®Google Scholar
• Winans E. Aripiprazole. Am J Health-Syst Pharm AJHP off J Am Soc Health-Syst Pharm. 2003;60(23):2437–2445.
   PubMed Web of Science ®Google Scholar
• Lee ES, Vidal C, Findling RL. A focused review on the treatment of pediatric patients with atypical antipsychotics. J Child Adolesc Psychopharmacol. 2018;28(9):582–605.
   PubMed Web of Science ®Google Scholar